Clinical trials: Dermatology
Atopic Dermatitis (AD)
Effectiveness of Psychodermatologic Educational Modules on Atopic Dermatitis Patient Outcomes
In a previous part of this study, we created educational modules about the psychodermatology of inflammatory skin conditions, with a particular emphasis on atopic dermatitis, for patients.
- Trial name
- NCT07009483
- Testing
- Patient education modules providing information on the psychological aspects of atopic dermatitis treatment and management.
- Where
- 3 sites in Canada
- Volunteers
- 57 people
- Sponsor
- University of Alberta
Skin Condition, Dermatology
Application of the Belle.AI Dermatological Image Reference System for Patient Diagnosis in an Active Clinical Setting
The goal of this research study is to test a new, investigational tool that uses artificial intelligence (AI) to help primary care providers assess skin conditions.
- Conditions
- Skin Condition, Dermatology, Dermatology/Skin - Other
- Trial name
- NCT06724627
- Testing
- Dermatology/Skin - Other
- Where
- United States
- Volunteers
- 263 people
- Sponsor
- BelleTorus Corporation
Psoriasis
Tunisian National Registry on Psoriasis
National cross-sectional multicentric study to describe the epidemiological characteristics of patients with Psoriasis in Tunisia
- Trial name
- PsoTReg (NCT05258838)
- Where
- Tunisia
- Volunteers
- 1,100 people
- Sponsor
- Dacima Consulting
Dermatologic Disease
Addressing Inequity in Dermatology
The objectives of this study are to understand the variation in dermatoses presenting in individuals from different ancestry backgrounds. This will be conducted at multiple NHS hospitals in England.
- Trial name
- NCT06056648
- Where
- United Kingdom
- Volunteers
- 200 people
- Sponsor
- University of Manchester
Acne Vulgaris
The Development and Evaluation of an "E-Visit" Program for the Management of Acne
The purpose of this study is to test the efficacy, timeliness, and user satisfaction of an online "E-Visit" application that uses store-and-forward technology for acne patients requiring dermatologic care for their condition.
- Trial name
- NCT00417456
- Testing
- Evisit, Office visit
- Where
- 2 sites in United States
- Volunteers
- 151 people
- Sponsor
- Massachusetts General Hospital
Atopic Dermatitis, Atopic Dermatitis and Related Conditions
Efficacy and Safety of Blue Cap for the Treatment of Atopic Dermatitis in Children
To verify the efficacy and tolerability of Activated Piroctone Olamine (Blue Cap Foam, label volume 100 ml) by CATALYSIS, S. L. Madrid, applied in the management of all types of dermatitis (atopic, seborrheic, eczema) in patients…
- Conditions
- Atopic Dermatitis, Atopic Dermatitis and Related Conditions, Atopic Dermatitis Eczema, Atopic Dermatitis \(AD\)
- Trial name
- NCT06361992
- Testing
- Blue Cap Foam
- Where
- 3 sites in Serbia
- Volunteers
- 58 people
- Sponsor
- Catalysis SL
Acne Vulgaris
Oral Probiotics on the Microbiome and Lipidome in Acne Vulgaris
The purpose of this study is to determine how probiotics affect sebum production and gut health in those with acne vulgaris.
- Trial name
- NCT04596748
- Testing
- Probiotic
- Where
- United States
- Volunteers
- 70 people, healthy volunteers welcome
- Sponsor
- Integrative Skin Science and Research
Granuloma Annulare
Evaluation of 41 Cases of Pediatric Granuloma Annulare
INTRODUCTION: Granuloma annulare is a non-infectious, granulomatous disease that can affect children and adults. Although there are many studies examining adult patients, there are limited studies examining pediatric granuloma…
- Trial name
- NCT05472636
- Where
- Turkey (Türkiye)
- Volunteers
- 41 people
- Sponsor
- Istanbul Training and Research Hospital
Lichen Planus, Oral
Hydroxychloroquine vs. Clobetasol Rinse to Treat Oral Lichen Planus
This study will compare two treatments for oral lichen planus - hydroxychloroquine (Plaquenil) tablets and clobetasol oral rinse.
- Trial name
- NCT00102557
- Testing
- Hydroxychloroquine
- Where
- United States
- Volunteers
- 74 people
- Sponsor
- National Institute of Dental and Craniofacial Research (NIDCR)
Neurofibromatosis 2, Dermatology/Skin - Other
Cutaneous and Mucosal Manifestations of Neurofribromatosis Type 2 in Children Under 15
.Neurofibromatosis type 2 is an inherently autosomal dominant genetic disease, but cases of mosaicism or de novo mutation are not uncommon. the prevalence is estimated at 1 / 60,000.
- Trial name
- NCT03893643
- Testing
- no intervention
- Where
- France
- Volunteers
- 1,000 people
- Sponsor
- Centre Hospitalier Universitaire de Nice
Dermatitis, Atopic
Spanish Academy of Dermatology and Venereology Registry of Atopic Dermatitis Therapy
The Spanish Registry of Systemic therapy in atopic eczema, BIOBADATOP, assesses drug safety and treatment effectiveness as well as treatment impact on quality of life in children and adults with atopic eczema receiving systemic…
- Trial name
- BIOBADATOP (NCT05674695)
- Testing
- Ciclosporin
- Where
- 9 sites in Spain
- Volunteers
- 2,500 people
- Sponsor
- Fundación Academia Española de Dermatología
Severe Nodular Acne
Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne
The purpose of this study is to compare the efficacy and safety of CIP-Isotretinoin and a marketed (generic) formulation of isotretinoin when both are administered twice daily with meals.
- Trial name
- NCT00975143
- Testing
- CIP-Isotretinoin, Isotretinoin
- Where
- 49 sites in United States, Canada
- Volunteers
- 925 people
- Sponsor
- Cipher Pharmaceuticals Inc.
Hidradenitis Suppurativa
The Ohio State University Dermatology Biorepository
This study will create and extend a source of clinical specimens for the future study of inflammatory skin disorders.
- Trial name
- NCT03146676
- Where
- United States
- Volunteers
- 175 people, healthy volunteers welcome
- Sponsor
- Ohio State University
Atopic Dermatitis
Comparing Aquaphor to Atopiclair and EpiCeram in Children With Mild to Moderate Atopic Dermatitis
The purpose of this study is to compare the efficacy and cost effectiveness of Aquaphor Healing Ointment, Atopiclair and EpiCeram as a monotherapy in mild to moderate AD.
- Trial name
- NCT01093469
- Testing
- Atopiclair Nonsteroidal Cream, Aquaphor Healing Ointment, EpiCeram
- Where
- United States
- Volunteers
- 39 people
- Sponsor
- Wake Forest University Health Sciences
Molluscum Contagiosum
A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for the Treatment of Molluscum Contagiosum
This trial will examine the safety, tolerability and efficacy of one strength of East Indian sandalwood oil (EISO) in a cream base compared to a placebo for treatment of molluscum contagiosum in pediatric subjects.
- Trial name
- NCT02024581
- Testing
- 10% East Indian sandalwood oil cream
- Where
- United States
- Volunteers
- 27 people
- Sponsor
- ViroXis Corporation
Down Syndrome, Alopecia Areata
Tofacitinib for Immune Skin Conditions in Down Syndrome
People with Down syndrome (DS) display widespread immune dysregulation, including several immune skin conditions. This study hypothesizes that pharmacological inhibition of the increased interferon (IFN) signaling seen in DS is…
- Conditions
- Down Syndrome, Alopecia Areata, Atopic Dermatitis / Eczema, Hidradenitis Suppurativa
- Trial name
- NCT04246372
- Testing
- Tofacitinib
- Where
- United States
- Volunteers
- 47 people
- Sponsor
- University of Colorado, Denver
Skin Lesions
Human-AI Uncertainty Callibration for Improved Skin Lesion Segmentation
The goal of this randomized controlled study is to compare the effect of a new, personalized uncertainty-aware decision model (FDM) to a standard image recognition model in improving the diagnostic accuracy while reducing…
- Trial name
- NCT07468357
- Testing
- Base Model, FDM
- Volunteers
- 50 people, healthy volunteers welcome
- Sponsor
- Copenhagen Academy for Medical Education and Simulation
Dermatitis, Atopic
A Multicenter Randomized Control Trial in Children With Moderate to Severe Atopic Dermatitis to Assess the Benefit of a Nurse-led One-to-one Education Program in Addition to Standard Care Compared to Standard Care Alone on the Long Term Control of Disease Severity at 6 Months
Atopic dermatitis is a chronic relapsing disease, which is highly prevalent in children (15%). Therapeutic patient education (TPE) has been recognized as a key priority topic for future AD research.
- Trial name
- EDUDA (NCT02634905)
- Testing
- Individual session therapeutic education, Phone Call
- Where
- 11 sites in France
- Volunteers
- 178 people
- Sponsor
- Nantes University Hospital
Hyperpigmentation, Pediatric Dermatology
A Study on Pigmentation Disorders in Children
The descriptive cross-sectional study was undertaken at Kanti Children's Hospital during the period from January 2020 to June 2021.
- Trial name
- NCT06189768
- Where
- Nepal
- Volunteers
- 299 people, healthy volunteers welcome
- Sponsor
- Nepal Health Research Council
Psoriasis, Quality of Life
Assessment of Dermatologic Family Impact Scale in the Parents of Children With Psoriasis
The Dermatological Diseases Family Impact Scale (DeFIS) was developed to assess different aspects of health-related quality of life in the relatives of the patients with various skin diseases.
- Trial name
- NCT02796014
- Where
- 7 sites in Turkey (Türkiye)
- Volunteers
- 129 people
- Sponsor
- Istanbul Medeniyet University